| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |